Search results for

Indonesian IP laws have always required IP rights licences in Indonesia to be recorded at the Intellectual Property Office. This requirement is set out on the Copyright Law, Patent Law, Trade Mark Law, Industrial Design Law, Layout Designs of Integrated Circuits Law and Trade Secrets Law. However, such recordal mechanism has not been carried out due to the lack of implementing regulation, even though the legal consequence is that, if an IP licence is not recorded, it would not be binding on any third parties.

The Council of Ministers of Mozambique approved a new Mozambique Industrial Property Code on December 31 2015, which will come into force on March 31 2016, replacing the 2006 Industrial Property Code.

The Patent Trial and Appeal Board has narrowed its definition of what constitutes a covered business method, causing a fall in filing, but the treatment varies by panel. The Federal Circuit may provide more clarity in its upcoming Unwired Planet v Google opinion, practitioners tell Michael Loney

Tim Moss took over as chief executive of the UK IPO on May 1. Three months on, he talked to James Nurton about his ambitions, Brexit and being an “honest broker”

Provisions on patent term extension vary greatly in different jurisdictions. Kathryn D Soulier and Noel E Day provide a guide to the maze of regulations, and advise on how to get maximum protection

AIA Trial Practice Guide changes attracting the most attention are patent owners getting sur-replies and the opportunity to present a brief sur-rebuttal at the oral hearing, giving them the final word in PTAB proceedings

The Federal Circuit has issued more than 100 decisions on PTAB appeals. But practitioners report many issues remain unsolved, one of which is whether the appeals court can cope with the caseload

Michael Loney reveals interesting talking points from this month’s XIX Work Sessions and Administrative Council of ASIPI in Buenos Aires, including lessons from TPP, the Latin American Trademark Impact Study, the responsibility of ISPs for third party content, the limits of biotechnology, and the scope of athlete’s image rights

European in-house counsel at Novartis, DSM and other generics and originator manufacturers tell Managing IP about the prospects and problems of individual treatments, particularly as AI plays a bigger role in making them

Will Corbett and David Stone present a series of options for protecting a design without disclosing it to competitors